In this monograph, experts evaluate the latest data to support neoadjuvant and adjuvant immunotherapy approaches as well as immunotherapy for metastatic melanoma. They ll also discuss patient and tumor characteristics that can inform treatment decisions, and review strategies for the recognition and management of immunotherapy-related adverse events.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/hematology-oncology/20241119/advanced-melanoma-immunotherapy-landscape-positioning-novel-and-emerging-agents/overview
- Start Date: 2024-11-01 05:00:00
- End Date: 2024-11-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
- Commercial Support: Source: Merck & Co., Inc. - Amount: 33333.33 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest